225 related articles for article (PubMed ID: 9391085)
21. Role of SV40 T antigen binding to pRB and p53 in multistep transformation in vitro of human uroepithelial cells.
Kao C; Huang J; Wu SQ; Hauser P; Reznikoff CA
Carcinogenesis; 1993 Nov; 14(11):2297-302. PubMed ID: 8242858
[TBL] [Abstract][Full Text] [Related]
22. Application of a telomerase-based circulating tumor cell (CTC) assay in bladder cancer patients receiving postoperative radiation therapy: a case study.
Ju M; Kao GD; Steinmetz D; Chandrasekaran S; Keefe SM; Guzzo TJ; Christodouleas JP; Hahn SM; Dorsey JF
Cancer Biol Ther; 2014 Jun; 15(6):683-7. PubMed ID: 24618718
[TBL] [Abstract][Full Text] [Related]
23. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine.
Yoshida K; Sugino T; Tahara H; Woodman A; Bolodeoku J; Nargund V; Fellows G; Goodison S; Tahara E; Tarin D
Cancer; 1997 Jan; 79(2):362-9. PubMed ID: 9010110
[TBL] [Abstract][Full Text] [Related]
24. 17beta-estradiol induces the proliferation of the in vitro cultured human urothelium.
Koskela S; Lehtonen S; Santala M; Venhola M; Parpala-Spårman T; Lehenkari P
Scand J Urol Nephrol; 2009; 43(3):179-85. PubMed ID: 19384677
[TBL] [Abstract][Full Text] [Related]
25. Altered growth patterns in vitro of human papillary transitional carcinoma cells.
Reznikoff CA; Gilchrist KW; Norback DH; Cummings KB; Ertürk E; Bryan GT
Am J Pathol; 1983 Jun; 111(3):263-72. PubMed ID: 6859216
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic value of urinary molecular markers in bladder cancer.
Eissa S; Swellam M; el-Mosallamy H; Mourad MS; Hamdy NΜ; Kamel K; Zaglol AS; Khafagy MM; el-Ahmady O
Anticancer Res; 2003; 23(5b):4347-55. PubMed ID: 14666650
[TBL] [Abstract][Full Text] [Related]
27. Nonrandom chromosome losses in tumorigenic revertants of hybrids between isogeneic immortal and neoplastic human uroepithelial cells.
Klingelhutz AJ; Wu SQ; Reznikoff CA
Somat Cell Mol Genet; 1991 Nov; 17(6):551-65. PubMed ID: 1767334
[TBL] [Abstract][Full Text] [Related]
28. Telomerase activity and cytokeratin 20 as markers for the detection and followup of transitional cell carcinoma: an unfulfilled promise.
Cassel A; Rahat MA; Lahat N; Lindenfeld N; Mecz Y; Stein A
J Urol; 2001 Sep; 166(3):841-4. PubMed ID: 11490230
[TBL] [Abstract][Full Text] [Related]
29. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.
Klein A; Zemer R; Buchumensky V; Klaper R; Nissenkorn I
Cancer; 1998 Jan; 82(2):349-54. PubMed ID: 9445193
[TBL] [Abstract][Full Text] [Related]
30. Loss of prostasin (PRSS8) in human bladder transitional cell carcinoma cell lines is associated with epithelial-mesenchymal transition (EMT).
Chen LM; Verity NJ; Chai KX
BMC Cancer; 2009 Oct; 9():377. PubMed ID: 19849847
[TBL] [Abstract][Full Text] [Related]
31. Semi-quantitative analysis of telomerase activity in exfoliated human urothelial cells and bladder transitional cell carcinoma.
Yokota K; Kanda K; Inoue Y; Kanayama H; Kagawa S
Br J Urol; 1998 Nov; 82(5):727-32. PubMed ID: 9839590
[TBL] [Abstract][Full Text] [Related]
32. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues.
Kolquist KA; Ellisen LW; Counter CM; Meyerson M; Tan LK; Weinberg RA; Haber DA; Gerald WL
Nat Genet; 1998 Jun; 19(2):182-6. PubMed ID: 9620778
[TBL] [Abstract][Full Text] [Related]
33. Glutathione S-transferase T1-1 activity upregulated in transitional cell carcinoma of urinary bladder.
Simic T; Mimic-Oka J; Savic-Radojevic A; Opacic M; Pljesa M; Dragicevic D; Djokic M; Radosavljevic R
Urology; 2005 May; 65(5):1035-40. PubMed ID: 15882759
[TBL] [Abstract][Full Text] [Related]
34. Decrease of DNA methyltransferase 1 expression relative to cell proliferation in transitional cell carcinoma.
Kimura F; Seifert HH; Florl AR; Santourlidis S; Steinhoff C; Swiatkowski S; Mahotka C; Gerharz CD; Schulz WA
Int J Cancer; 2003 May; 104(5):568-78. PubMed ID: 12594811
[TBL] [Abstract][Full Text] [Related]
35. Expression of the RNA component of human telemorase (hTR) in ThinPrep preparations from bladder washings.
Maitra A; Rathi A; Gazdar AF; Sagalowsky A; Ashfaq R
Cancer; 2001 Feb; 93(1):73-9. PubMed ID: 11241269
[TBL] [Abstract][Full Text] [Related]
36. Development of retinoblastoma in the absence of telomerase activity.
Gupta J; Han LP; Wang P; Gallie BL; Bacchetti S
J Natl Cancer Inst; 1996 Aug; 88(16):1152-7. PubMed ID: 8757195
[TBL] [Abstract][Full Text] [Related]
37. Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder.
Ristimäki A; Nieminen O; Saukkonen K; Hotakainen K; Nordling S; Haglund C
Am J Pathol; 2001 Mar; 158(3):849-53. PubMed ID: 11238034
[TBL] [Abstract][Full Text] [Related]
38. Microsatellite analysis and telomerase activity in archived tissue and urine samples of bladder cancer patients.
Linn JF; Lango M; Halachmi S; Schoenberg MP; Sidransky D
Int J Cancer; 1997 Dec; 74(6):625-9. PubMed ID: 9421360
[TBL] [Abstract][Full Text] [Related]
39. Evidence for elevated telomerase activity in small cell carcinoma of the bladder.
Selli C; Gelmini S; Scott CA; Crisci A; Giannarini G; Orlando C
Urology; 2000 Aug; 56(2):331. PubMed ID: 10925114
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA HOTAIR is a prognostic biomarker and inhibits chemosensitivity to doxorubicin in bladder transitional cell carcinoma.
Shang C; Guo Y; Zhang H; Xue YX
Cancer Chemother Pharmacol; 2016 Mar; 77(3):507-13. PubMed ID: 26781446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
